|
 
- 现金
- 514 元
- 精华
- 0
- 帖子
- 279
- 注册时间
- 2011-8-19
- 最后登录
- 2015-5-29
|
Arrowhead Research Corporation (ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the Company is presenting at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society being held on October 12-15, 2014 in San Diego. Scheduled conference presentations include the following:
October 12, 2014 – A poster presentation titled, “Kinetics of DPC-mediated delivery of cholesterol-conjugated RNAi triggers and their subcellular processing in vivo,” will be presented by Christine Woodell, Ph.D., Group Leader
October 15, 2014 – An oral presentation titled, “Development of RNAi-based therapeutics using Dynamic Polyconjugate (DPC) delivery technology,” will be presented by David Lewis, Ph.D., Chief Scientific Officer |
|
楼主: 林伍伍
发表于 2014-10-1 12:42
